Search

everythinglearnresearchcommunity

for

Search:↓

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

DPCP can help regrow hair in some people with severe alopecia.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Targeting ornithine decarboxylase can help prevent skin cancer.

Rituximab may cause skin issues, but baricitinib can help improve them.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

The treatment combination is effective and generally safe for lung cancer.

Wnt/β-catenin signaling is crucial for cell fusion in placental development.

pbn-STAC effectively finds strategies for cellular reprogramming using deep reinforcement learning.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

The treatment was effective and tolerable for advanced gastric cancer.